You just read:

Amerigen believes that it is a first applicant to file an Abbreviated New Drug Application ("ANDA") for certain strengths of Namzaric® containing a "Paragraph IV" patent certification under the provisions of the Hatch-Waxman Act

News provided by

Amerigen Pharmaceuticals

Sep 05, 2017, 09:37 ET